Chargement en cours...
The Selective Estrogen Receptor Modulator Raloxifene Inhibits Neutrophil Extracellular Trap Formation
Raloxifene is a selective estrogen receptor modulator typically prescribed for the prevention/treatment of osteoporosis in postmenopausal women. Although raloxifene is known to have anti-inflammatory properties, its effects on human neutrophils, the primary phagocytic leukocytes of the immune system...
Enregistré dans:
| Publié dans: | Front Immunol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5141331/ https://ncbi.nlm.nih.gov/pubmed/28003814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2016.00566 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|